Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive disease due to aggregation of fibroblasts on lung parenchyma. Nintedanib, an indolinone-derived tyrosine kinase inhibitor (TKi) has been approved for the treatment of IPF and it is a well-known inhibitor of platelet-derived growth factor (PDGF) re...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya
2024-08-01
|
| Serie: | Borneo Journal of Pharmacy |
| Soggetti: | |
| Accesso online: | https://journal.umpr.ac.id/index.php/bjop/article/view/7218 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|